Saguaro

Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research

Quebec City, Canada, June 4th 2024 – Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable […]

Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research Read More »

Saguaro and Funakoshi Enter Distribution Agreement to make New Non-Toxic Dye Technology Available to Japan

November 17, 2022. QUEBEC CITY & TOKYO–(BUSINESS WIRE)–Saguaro Technologies inc., a cell culture product company that offers a first-of-a-kind dye technology, and Funakoshi Co., Ltd., a top Japanese distributor of life science reagents and products, announces the establishment of a new distribution agreement where Funakoshi will help Saguaro accelerate sales of its products to the

Saguaro and Funakoshi Enter Distribution Agreement to make New Non-Toxic Dye Technology Available to Japan Read More »

Saguaro Announces Exclusive Worldwide License Agreement with Sunnybrook Research Institute for ChromaLive™ dyes

Bringing new biology to light! QUÉBEC CITY, March 23, 2022 /CNW/ – Saguaro Technologies inc. announces today an exclusive worldwide license agreement with Sunnybrook Research Institute (SRI) on small molecules for live-cell imaging. These new molecules, which are now part of Saguaro’s proprietary series of high-performance dyes (ChromaLiveTM), were developed by David Andrews, PhD, Director of Biological Sciences

Saguaro Announces Exclusive Worldwide License Agreement with Sunnybrook Research Institute for ChromaLive™ dyes Read More »

Saguaro Closes $1.1M Start-Up Funding to Offer New Drug Discovery Technologies That Help Fight Human Disease

February 16, 2022. QUEBEC CITY–(BUSINESS WIRE)–Saguaro Technologies Inc. announces the closing of a $1.1M start-up financing led by a seasoned biotech investor and including non-dilutive grant funding. “We are pleased to close our first financing and to welcome Frederic Ors as lead investor and strategic advisor to Saguaro. Frederic is a well-recognized executive with a

Saguaro Closes $1.1M Start-Up Funding to Offer New Drug Discovery Technologies That Help Fight Human Disease Read More »

Fill the form

 


[wpforms id="59"]

This will close in 0 seconds

Fill the form

 


[wpforms id="59"]

This will close in 0 seconds

Fill the form

 



[wpforms id="59"]

This will close in 0 seconds

Fill the form

 



[wpforms id="59"]

This will close in 0 seconds